Piozer Tablets 30Mg

Brand : hilton pharma

Rs. 249.41

Rs. 262.50

|

QUICK DELIVERY

SPECIFICATION

Requires Prescription (YES/NO)

Yes

Generics

Pioglitazone HCl

Used For

Diabetes

How it works

Pioglitazone is a thiazolidinedione antidiabetic agent that depends on the presence of insulin for its mechanism of action. Pioglitazone decreases insulin resistance in the periphery and in the liver resulting in increased insulin-dependent glucose disposal and decreased hepatic glucose output. Unlike sulfonylureas, pioglitazone is not an insulin secretagogue. Pioglitazone is a potent and highly selective agonist for peroxisome proliferator-activated receptor-gamma (PPAR?). PPAR receptors are found in tissues important for insulin action such as adipose tissue, skeletal muscle, and liver. Activation of PPAR? nuclear receptors modulates the transcription of a number of insulin responsive genes involved in the control of glucose and lipid metabolism.

USAGE AND SAFETY

Dosage

Pioglitazone HCl

Side Effects

Very Common : Hypoglycaemia, edema.Common : Visual disturbances, upper respiratory tract infection, weight increase, hypoaesthesia, anemia, arthralgia, headache, haematuria, erectile dysfunction, flatulence, dizziness, blood creatine phosphokinase increase, bronchitis, back pain, dyspnoea, heart failure.Rare : Sinusitis, flatulence, vertigo, fatigue, increased lactic dehydrogenase, appetite increased, hypoglycaemia, headache, glycosuria, proteinuria, sweating.

Drug Interactions

Midazolam , Gemfibrozil , Rifampicin.

Indication

It is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.

When not to Use

Pioglitazone is contraindicated in patients with: • Hypersensitivity to the active substance or to any of the excipients. • Cardiac failure or history of cardiac failure (NYHA stages I to IV). • Hepatic impairment • Diabetic ketoacidosis.

PRECAUTIONS

Precaution

Pioglitazone exerts its antihyperglycemic effect only in the presence of insulin. Therefore, pioglitazone should not be used in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis.

WARNINGS

Warning 1

Patients receiving pioglitazone in combination with insulin or oral hypoglycemic agents may be at risk for hypoglycemia, and a reduction in the dose of the concomitant agent may be necessary.

Warning 2

Pioglitazone may cause decreases in hemoglobin and hematocrit.

Warning 3

Dose related weight gain may occur with pioglitazone alone and in combination with other hypoglycemic agents.